Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Equities research analysts at William Blair lifted their Q1 2024 EPS estimates for shares of Fusion Pharmaceuticals in a research report issued to clients and investors on Thursday, March 21st. William Blair analyst A. Hsieh now forecasts that the company will post earnings per share of ($0.39) […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high on Monday . The company traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares traded. The stock had previously closed at $21.24. Analysts Set New Price Targets Several brokerages have issued reports on […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares trading hands. The stock had previously closed at $21.24. Analyst Ratings Changes Several analysts have commented on […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Investment analysts at Wedbush decreased their Q1 2024 EPS estimates for Fusion Pharmaceuticals in a research note issued to investors on Wednesday, March 20th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.34) per share for the quarter, down from their prior estimate of […]